Nasdaq

Revolution Medicines Presents Encouraging Clinical Data for RMC-6236 and RMC-6291 at 2023 Triple Meeting

REDWOOD CITY, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today ...
Nasdaq

Revolution Medicines presents data from RMC-6236 Monotherapy Study

Revolution Medicines (RVMD) announced encouraging antitumor activity and safety/tolerability data for RMC-6236, its RAS multi-selective inhibitor, in patients with previously treated pancreatic ductal ...
Yahoo Finance

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor ...

REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted ...
Yahoo Finance

Revolution Medicines Presents Updated Data from RMC-6236 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma

REDWOOD CITY, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today ...
Electronic Design

Universal AC Input Vita 62 3U Power Supply

Dawn VME Products announces the PSC-6236 universal AC input VITA 62 compliant 6 channel 3U OpenVPX power supply with up to 400 watts output for air or conduction cooled systems. Dawn VME Products ...